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AbstrAct
Introduction Pain can affect people regardless of age, 
gender or ethnicity. Chronic central neuropathic pain 
(CCNP) is a debilitating condition that affects populations 
such as stroke survivors, amputees, spinal cord injury 
patients and patients with multiple sclerosis, with 
prevalence rates between 30% and 80%. This condition 
can be caused by a lesion or disease affecting the 
somatosensory system. CCNP is notoriously drug resistant, 
and few effective CCNP treatment or management 
strategies exist. The emergence of non-invasive brain 
stimulation and neuromodulation techniques provide 
novel avenues for managing chronic central neuropathic 
pain. This scoping review aims to systematically identify 
the methods and effectiveness of non-invasive brain 
stimulation techniques for treating and managing chronic 
central neuropathic pain.
Methods and analysis The following databases will be 
searched systematically: PubMed, EMBASE, Cumulative 
Index to Nursing and Allied Health Literature (CINAHL), 
Institute of Electric and Electronic Engineers (IEEE), 
Association of Computing Machinary (ACM) and Scopus. 
Additional literature will be identified by searching the 
reference lists of identified studies. Studies will include 
reviews and original research in both published and grey 
literatures. Two reviewers will independently screen 
identified studies for final inclusion. A quantitative analysis 
on the intervention type, application and efficacy will be 
synthesised along with a qualitative analysis to describe 
the effectiveness of each intervention.
Ethics and dissemination No primary data will be 
collected and hence formal ethics review is not required. 
The results of the scoping review will be presented 
at relevant national and international conferences, 
published in a peer-reviewed journal and provided to the 
stakeholders with plain language to be posted on their 
websites. This scoping review will provide a foundation to 
guide the development of future primary research on non-
invasive brain stimulation and CCNP. 
IntroductIon
Pain is a critical mechanism for harm preven-
tion. However, the experience of chronic 
pain can dramatically reduce one’s quality 
of life, affecting the individual, their families 
and society at large.1 2 Pain is defined by the 
International Association for the Study of 
Pain (IASP) as: ‘an unpleasant sensory and 
emotional experience associated with actual 
or potential tissue damage, or described in 
terms of such damage’.3 Specifically, the IASP 
defined neuropathic pain as ‘pain caused 
by a lesion or disease of the somatosensory 
nervous system’.3 Neuropathic pain is a clin-
ical description (and not a diagnosis) that 
requires a demonstrable lesion or a disease 
that satisfies established neurological diag-
nostic criteria.3 The term lesion is commonly 
used in diagnostic investigations (eg, imaging, 
neurophysiology, biopsies and lab tests) to 
reveal an abnormality or obvious trauma. 
The term disease is commonly used when 
the underlying cause of the lesion is known 
(eg, stroke, vasculitis, diabetes mellitus and 
genetic abnormality). Somatosensory refers 
to information about the body including 
visceral organs.3 
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Protocols
strengths and limitations of this study
 ► This study protocol provides an overview of the 
current status of the field to inform the development 
of a scoping review of non-invasive brain stimulation 
interventions for the management of chronic central 
neuropathic pain.
 ► The scoping review will identify gaps in research 
and in the translation of research results into clinical 
practice.
 ► The scoping review is specific to active stimu-
lation interventions, excluding pharmacotherapy 
interventions.
 ► A limitation is that this scoping review that aims to 
explore the field for existing methods rather than a 
systematic review that seeks to answer a specific 
question.
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The burden of disability associated with neuropathic 
pain is substantial and includes healthcare costs, time and 
quality of life.4 The health-related quality of life for people 
with neuropathic pain is comparable with cancer or chronic 
heart failure.5 In Canada, chronic pain involves healthcare 
costs that exceed $6 billion per year and productivity costs 
at $37 billion per year.6 Furthermore, an analysis of a large 
US insurance database revealed that healthcare costs of 
patients with neuropathic pain were three times greater 
than those of age-matched and sex-matched claimants 
without neuropathic pain.7
Currently, there exists no treatment to prevent the devel-
opment of neuropathic pain following injury to the somato-
sensory system, neither is there a method to specifically 
control the pain when it is established. Pharmacotherapy 
for neuropathic pain has been generally disappointing8–11; 
patients with neuropathic pain do not respond well to 
non-steroidal anti-inflammatory drugs, and resistance or 
insensitivity to opiates is common.2 12 13 Examples of phar-
macological treatments include tricyclic or serotonin and 
norepinephrine uptake inhibitors, antidepressants and 
anticonvulsants, which all have limited efficacy and undesir-
able side effects.2 8 Ancillary treatments such as physical and 
psychological interventions are often used to help patients 
cope with pain, although they are less effective for severe 
pain.9
Alternatively, a number of invasive and non-invasive stim-
ulation techniques are increasingly being proposed either 
as a substitute for or in combination with current medical 
therapies.9 Peripheral stimulation techniques include: 
transcutaneous electrical nerve stimulation (TENS) and 
nerve root stimulation (NRS). TENS involves surface elec-
trodes placed over the painful area or its associated nerve, 
delivers stimulation at high frequency and low intensity to 
activate the Aβ afferents and evokes paraesthesia in the pain 
area, providing short-term (20–30 min) pain relief in accor-
dance with the gate-control theory.9 NRS involves implanta-
tion of an electrode in the root exit from the spine. These 
peripheral stimulation techniques provide only temporary 
pain relief that lasts for the duration of the stimulation.9 
Other invasive stimulation techniques include: spinal cord 
stimulation (SCS), deep brain stimulation (DBS) and 
motor cortex stimulation (MCS). These procedures involve 
the implantation of a stimulating device into their respec-
tive target areas: SCS targets the posterior thoracic space of 
the thoracic or cervical spine, DBS targets the sensory thal-
amus or periventricular grey matter and MCS targets the 
motor cortex. The effectiveness of these invasive techniques 
varies significantly across patients14 and their mechanisms 
of action are unclear.15 Furthermore, the techniques are 
only applicable to patients who can safely undergo surgery.9
Examples of non-invasive brain stimulation tech-
niques include: transcranial direct-current stimulation 
(tDCS),14 16 and repetitive transcranial magnetic stimula-
tion (rTMS).9 17 18 Both stimulation techniques are adjust-
able and reversible.9 tDCS has shown promising results in 
inducing cortical-plasticity with clinical benefits.19 It passes 
a weak (commonly ≤2 mA) monophasic electric current to 
the cerebral cortex through the scalp, modifying neuron 
membrane excitability, leading to neuroplasticity.19 A 
single tDCS session can induce transient cortical effects, 
but daily sessions may induce longer lasting effects.19 For 
rTMS, the stimulation is applied using a magnetic stim-
ulation coil placed against the head. A rapidly changing 
magnetic field is induced in the coil that generates an 
electrical current in the cortical area below the coil. rTMS 
has been found to affect neuropathic pain processing.9 20 
The clinical effects are modest and short-lasting from a 
single session,9 but repeated sessions may cause greater 
and longer lasting effects. There exists equivocal evidence 
and differing perspectives on the effects of rTMS; for 
instance, one study suggests that rTMS can produce long-
lasting pain relief,17 while another states that its effects 
are uncertain and may be mediated by other factors such 
as mood.21 Given that non-invasive brain stimulation may 
relieve neuropathic pain, and the effect size is modest, 
there is significant heterogeneity between studies that 
should be further investigated.22
There is a need for a systematic overview of the existing 
evidence to support further research.
Previous reviews have been done to gather the research 
evidence on isolated topics and NIBS techniques for 
specific conditions. However, a broad scoping review with 
a clear search strategy is needed to scope the wide-ranging 
evidence for non-invasive brain stimulation techniques 
for chronic central neuropathic pain. This scoping review 
will fill this gap by summarising the breadth, depth and 
clinical applications of current non-invasive brain stim-
ulation interventions for chronic central neuropathic 
pain, distilling the existing research to support the future 
development of primary research.23 24
AIM
This article describes a protocol for a scoping review that 
will locate, summarise and report literature that informs 
the current and proposed non-invasive brain stimulation 
interventions for chronic central neuropathic pain, as 
well as identify areas to direct future research.
The scoping review will:
1. review the breadth and depth of peer-reviewed 
literature that has examined or evaluated the 
application of non-invasive brain stimulation 
techniques to chronic central neuropathic pain in 
technology and medical databases;
2. review the extent and nature of a sampling of 
non-peer-reviewed non-invasive brain stimulation 
interventions for chronic central neuropathic pain 
from key organisational websites, professional 
regulatory bodies and special interest organisations 
and disease-specific groups.
MEthods And AnAlysIs
Our scoping team of reviewers will be multidisciplinary, 
comprising of clinician-researchers, engineering 
researchers and health researchers. The scoping review 
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methodology laid out by Arksey and O’Malley24 and 
further clarified by Levac et al23 will be used. The approach 
will review the existing literature and provide transpar-
ency, reproducibility and utility within this protocol.25
Identifying the research question
The research question was framed by assimilating themes 
from preliminary searches, and opinions were sought 
from experts in the field of pain rehabilitation and 
neurotechnology. Using a concept, target population and 
outcomes of interest approach, we formulated a broad 
research question: ‘What are the nature, adherence, 
extent, efficacy, exposure, quality of delivery and clinical 
application of non-invasive brain stimulation techniques 
currently used and proposed in managing chronic central 
neuropathic pain?’. 
Eligibility criteria
The following inclusion criteria were used to guide the 
search and will be used when reviewing articles:
 ► published in the English language
 ► human subjects with chronic central neuropathic pain
 ► years of publication: none specified
 ► all age groups





 ► narrative reviews
 ► books and book chapters
 ► lectures and addresses
 ► animal studies.
types of study
Meta-analysis, systematic reviews, randomised control 
trials, cohort studies, case–control studies, case series/
case reports and cross-sectional trials.
databases
Published studies will be identified from the following 
electronic database: PubMed, Embase, Cumulative Index 
to Nursing and Allied Health Literature, IEEE, ACM and 
Scopus. Additional literature will be identified by hand 
searching the reference list of identified eligible studies 
and as well through identified grey literature sources.
search strategy
The in-depth search strategy has been developed in each 
of the six databases to capture the broad literature on the 
topic. In order to maximise the sensitivity of the search, 
the following steps will be taken: consult with experts in 
the field; search in clinical trials registers, conference 
proceedings and selected grey literature such as PhD 
theses; perform forward and backward citation tracking; 
contact the websites of key organisations; and hand-
search journal references.
Please see a sample search strategy in PubMed as 
follows:
(‘neuralgia’[MeSH Terms] OR ‘neuralgia’[All Fields] 
OR (‘neuropathic’[All Fields] AND ‘pain’[All Fields]) 
OR ‘neuropathic pain’[All Fields]) AND (‘therapy’[Sub-
heading] OR ‘therapy’[All Fields] OR ‘treatment’[All 
Fields] OR ‘therapeutics’[MeSH Terms] OR ‘thera-
peutics’[All Fields]) OR (‘Brain Stimul’[Journal] OR 
(‘brain’[All Fields] AND ‘stimulation’[All Fields]) OR 
‘brain stimulation’[All Fields]) OR (non[All Fields] AND 
invasive[All Fields]) AND (Clinical Trial[ptyp] AND 
‘humans’[MeSH Terms] AND English[lang]).
study selection
Study screening will be reported and guided according 
to Levac et al’s framework and the reporting will follow 
the Preferred Reporting Items for Systematics Reviews 
and Meta-analyses checklist and will be performed in four 
major stages.26 First, search results will be merged and 
duplicates will be removed via reference management 
software (EndNote V.X5). Second, a data extraction form 
based on the eligibility criteria described above will be 
developed by the research team. Third, a pilot test of this 
data extraction form will be performed: two reviewers 
will independently screen the first 25 titles, abstracts and 
grey literature of retrieved publications according to 
the eligibility criteria by using the data extraction form. 
Fourth, all eligible studies and those classified as unclear 
(needing more information) will be reviewed in full-text 
by each reviewer independently to determine if all inclu-
sion criteria are met and if the article is to be included 
in the study. Inter-rater agreement will again be calcu-
lated on a random sample of 25 articles. Disagreement 
on study eligibility will be discussed and resolved with a 
third reviewer.
data extraction
A customised data extraction form will be constructed to 
extract all relevant data from each study. Two reviewers 
will use the form to extract data from the first 15 eligible 
articles. Then they will meet to compare consistency of 
data extraction and coding. Clarification and updating of 
the extraction form will be an iterative process until all 
authors reach consensus on the final version. The data 
extraction form will be piloted on the first five eligible 
studies to evaluate its reliability in capturing the study 
data of interest. Data extraction will be undertaken inde-
pendently by two reviewers.
Descriptive summary tables will be produced to reca-
pitulate the evidence base. The following data will be 
extracted:
 ► author(s) and date
 ► geographical location
 ► research design
 ► aim
 ► research question
 ► methods
 ► settings
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 ► participant characteristics (total number, mean age, 
gender, pathology if available)
 ► primary cause of pain
 ► pain characteristics
 ► intervention studied/proposed
 ► intervention rationale/mechanism
 ► intervention frequency, site, duration of stimulation 
and the delay between times of stimulation and the 
clinical effects
 ► attitude towards intervention (positive or negative 
feelings towards intervention—from the healthcare 
provider; positive or negative feelings towards treat-
ment—from the participant/patient and so on)
 ► NIBS characteristic (intensity, number of pulses, 
montage, current pattern/waveform and duration)
 ► length of follow-up
 ► duration of effect
 ► patient response, participation and enthusiasm in 
intervention
 ► simultaneous interventions (if applicable)
 ► neuropathic pain comorbidities
 ► key findings
 ► research gaps identified
 ► Potential biases in study (assessed using the Cochrane 
Collaboration’s ‘Risk of bias’ tool for assessing risk of 
bias)26 
 ► pain outcome (visual analogue scale (VAS) if available)
 ► daily functioning outcome.
Other variables may be added when revising and 
updating the data extraction form after analysis of the 
first 15 eligible articles.
data synthesis
An initial map will be developed to explore the inter-
ventions available for chronic central neuropathic pain. 
The findings will be quantitatively and qualitatively 
synthesised for all identified interventions. The quanti-
tative synthesis will comprise of numerical counts such 
as number of interventions by setting and by applica-
tion. A qualitative description approach will be used 
to describe the characteristics of each intervention 
(ie, definition of intervention, mechanism, efficacy, 
side effects, frequency of use and feasibility) as well as 
pain outcome using the VAS. The change in VAS, for 
example, will be used to review the effectiveness of the 
intervention. The specific metrics that will be included 
will be determined after the papers have been identi-
fied and reviewed.
EthIcs And dIssEMInAtIon
There are no protected/private health information 
collected, hence there will be no need for formal ethical 
review. The results of the scoping review will be presented 
at relevant national and international conferences, 
published in a peer-reviewed journal and proposed to 
relevant stakeholders.
conclusIon
This scoping review will map key concepts and empirical 
results relating to the use of non-invasive brain stimula-
tion to treat and manage chronic central neuropathic 
pain. It will also provide a comprehensive evaluation 
of current methodologies and identify gaps for future 
research and share the key research findings with rele-
vant stakeholders.
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